Tonini Gerlomo, Kalantary Farschid, Teppa Alessandro, Rosini Roberto, Aulenti Vito, Tosana Michelangelo, Zorzi Fausto, Bianchi Denise
Divisione di Urologia, Fondazione Poliambulanza, Brescia, Italy.
Urologia. 2011 Jul-Sep;78(3):206-9. doi: 10.5301/RU.2011.8526.
The desmoid tumor is a rare tumor with an incidence of 2-4 cases per million people each year, and represents 0.03% of all cancers. The tumor is composed of fibrous tissue that produces masses of well-differentiated hard elastic consistency. According to their site of onset, the desmoid tumors are classified in abdominal, intra-abdominal, and extra-abdominal. The abdominal cases develop inside the abdominal muscles of the abdominal wall upright, especially in women in their 2nd - 4th decade of life, particularly in those who have been pregnant.
A 66-year-old patient underwent nephrectomy in 2006 for the detection of a massive tumor in the right kidney (EI: pT1bNx). The patient came to our observation for the radiological tracking (CT) of a solid lesion of 4 cm below the right arch, 2 years after surgery. For this reason it was decided to refer the patient to a series of percutaneous biopsies. The report describes a histologic lesion of fibromatosis. After one year a new CT exam showed a significant increase of the size of the lesion, with a diameter of 11.6 x 7.9 cm, and abdominal involvement to ascending colon. Given the discrepancy between the CT data and the histological report, it was decided to refer the patient to a lombotomic exploration and the subsequent removal of the lesion, which appeared of hard, elastic consistency and well capsulated. The final histology test confirmed the fibromatosis lesion.
The desmoid tumor is a rare tumor characterized by the proliferation of fibrotic tissue. The tumor is composed of well-differentiated fibrous tissue and has a hard-elastic consistency. Regarding the development of dermoid tumors, several risk factors were identified, including extra-abdominal fibromatosis, genetic factors, endocrine factors. Other causes may arise from trauma or abdominal injury in surgical outcomes of appendectomy, laparotomy and other surgical scars (scar fibromatosis) or genetic predisposing factors. The surgical resection of dermoid tumors should be the therapy of choice, complete and radical, to cover the possible excision of a wide margin of surrounding structures concerned, and those arrangements should ensure a low rate of relapse. However, in cases of inoperable cancer due to extension, anti-estrogen therapy may have an important therapeutic and well-tolerated effect, besides being relatively non-toxic, even at high doses. A close follow-up is indicated, however, and warmly recommended.
硬纤维瘤是一种罕见肿瘤,每年发病率为每百万人2 - 4例,占所有癌症的0.03%。该肿瘤由产生大量分化良好的硬弹性肿块的纤维组织构成。根据发病部位,硬纤维瘤分为腹壁、腹腔内和腹腔外三种类型。腹壁型病例发生于腹壁的腹肌内,尤其在20至40岁的女性中,特别是有过怀孕经历的女性。
一名66岁患者于2006年因右肾发现巨大肿瘤(EI:pT1bNx)接受了肾切除术。术后2年,患者因右肾弓下方4厘米处实性病变的放射学追踪检查(CT)前来我院就诊。因此,决定对患者进行一系列经皮活检。报告描述为纤维瘤病的组织学病变。一年后,新的CT检查显示病变大小显著增加,直径达11.6×7.9厘米,且累及升结肠。鉴于CT数据与组织学报告存在差异,决定对患者进行腰椎切开探查并随后切除病变,该病变质地硬、有弹性且包膜完整。最终组织学检查证实为纤维瘤病病变。
硬纤维瘤是一种以纤维组织增生为特征的罕见肿瘤。该肿瘤由分化良好的纤维组织构成,质地硬且有弹性。关于硬纤维瘤的发病,已确定了多种危险因素,包括腹腔外纤维瘤病、遗传因素、内分泌因素。其他病因可能源于创伤或腹部损伤,如阑尾切除术、剖腹手术等手术结果中的腹部损伤及其他手术疤痕(疤痕纤维瘤病)或遗传易感性因素。硬纤维瘤的手术切除应是首选治疗方法,要完整且彻底,以确保可能切除周围相关结构的宽切缘,这些措施应确保低复发率。然而,对于因肿瘤扩散而无法手术的癌症病例而言,抗雌激素治疗可能具有重要的治疗效果且耐受性良好,即使高剂量使用也相对无毒。不过,仍需密切随访,并强烈推荐。